U.S. Semiconductors Stock News

NYSE:PMT
NYSE:PMTMortgage REITs

PennyMac Mortgage Investment Trust (PMT) 13.52% Dividend Strain Tests Bullish Income Narratives

PennyMac Mortgage Investment Trust (PMT) has just wrapped up FY 2025 with fourth quarter revenue of US$93.6 million and basic EPS of US$0.48, alongside trailing twelve month revenue of US$307.5 million and EPS of US$0.99. Over recent periods, the trust has seen quarterly revenue move between US$145.3 million and US$215.6 million in 2025, with EPS ranging from a small loss of US$0.04 in Q2 to US$0.55 in Q3, setting up the latest print against a backdrop of shifting headline results. With...
NasdaqGM:ZLAB
NasdaqGM:ZLABBiotechs

Is UBS’s Global-Innovation Framing Rewriting Zai Lab’s (ZLAB) Long-Term Biopharma Platform Narrative?

In late January 2026, UBS began coverage of Zai Lab Limited, highlighting the company’s evolution from a China-focused commercial player into a broader global innovation platform in oncology and immunology. UBS framed Zai Lab as a distinct biopharma platform whose combination of China-based operations and fully owned global pipeline assets could reshape its development path over the coming years. Next, we’ll examine how UBS’s focus on Zai Lab’s global innovation ambitions influences the...
NYSE:NVST
NYSE:NVSTMedical Equipment

Envista Holdings Growth Push Pressures Returns And Market Share Prospects

Envista Holdings, NYSE:NVST, is seeing weaker returns on capital from its recent growth push. The company is finding it harder to defend market share in core dental equipment and technology lines. These shifts are raising questions about the durability of its traditional profit engines. Envista Holdings, NYSE:NVST, sits at a current share price of $23.47 after a mixed run, with the stock up 14.4% over the past year but down 43.0% over three years and 37.7% over five years. That kind of...
NYSE:SNDR
NYSE:SNDRTransportation

Schneider National (SNDR) Margin Compression To 1.8% Tests Bullish Earnings Growth Narrative

Schneider National (SNDR) has wrapped up FY 2025 with fourth quarter revenue of US$1.4 billion and basic EPS of US$0.13, alongside net income of US$22.1 million. This sets the tone for a year where trailing twelve month revenue reached US$5.7 billion and EPS came in at US$0.59. Over recent quarters the company has reported revenue in a range between US$1.3 billion and US$1.5 billion, with quarterly EPS moving between roughly US$0.11 and US$0.21. For investors, the key question now is how...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

Is IDEAYA Biosciences (IDYA) Pricing Reflect Its DCF Upside After Recent Share Pullback

If you are wondering whether IDEAYA Biosciences is trading at a fair price or not, you are in the right place because this article focuses squarely on what you are paying versus what you are getting. Despite some recent volatility, with the share price at US$32.19 and returns of 7.5% decline over 7 days, 6.9% decline over 30 days and 4.9% decline year to date, the stock still shows a 32.2% return over 1 year, 83.3% over 3 years and 67.2% over 5 years. Recent company specific developments and...
NYSE:TGNA
NYSE:TGNAMedia

Will TEGNA's (TGNA) Mobile App Push and Award-Winning Journalism Deepen Its Local-Media Moat?

TEGNA Inc. recently rolled out new personalized local news and weather apps across 50 markets and saw audience engagement climb, while its Atlanta NBC affiliate WXIA (11Alive) won the 2026 Alfred I. duPont-Columbia University Award for the “Help That Harms” investigation that drove statewide policy reforms in Georgia. Together, the surge in mobile usage and high-profile recognition for impactful journalism underscore TEGNA’s strengthening connection with local audiences and public...
NYSE:SPHR
NYSE:SPHREntertainment

Sphere Entertainment Tests Smaller Sphere Model With Maryland National Harbor Plan

Sphere Entertainment (NYSE:SPHR) announced plans for a new venue at National Harbor in Maryland, its second U.S. location. The project will use a smaller scale design compared with the company’s existing U.S. venue. The development is expected to bring Sphere’s immersive entertainment concept to the Washington, D.C. metropolitan area. Company communications highlight anticipated economic, cultural, and community impacts, including job creation and public private investment. Sphere...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

Is Fox (FOXA) Still Attractive After A 43.5% One Year Share Price Jump

If you are wondering whether Fox shares still offer value after recent gains, this article will walk through what the current price could be implying about the company. Fox closed at US$72.78, with returns of 43.5% over 1 year and 147.2% over 5 years. This is the case even though the stock is roughly flat over the last month and year to date. Recent price moves sit against a backdrop of ongoing interest in US media groups and how they position themselves across traditional TV and digital...
NYSE:CNH
NYSE:CNHMachinery

CNH Industrial’s R4 Robot Extends Automation Push Into Specialty Crop Services

CNH Industrial (NYSE:CNH) has introduced its R4 autonomous robot, aimed at addressing labor shortages in specialty crop farming. The launch focuses on automated solutions for tasks in high value crops where finding and retaining workers can be difficult. This move builds on CNH Industrial's broader push into automation and robotics within agriculture equipment. For you as an investor, the R4 robot sits at the intersection of machinery, software, and farm operations, an area that has been...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

Is Tilray Brands' (TLRY) Italian Medical Push Quietly Redefining Its Global Cannabis Strategy?

Earlier in January 2026, Tilray Medical, a division of Tilray Brands, expanded its European medical cannabis operations by launching Tilray Medical Italia, rebranding the former FL Group and broadening an Italian Ministry of Health–authorized product portfolio in partnership with Molteni Farmaceutici. This move not only deepens Tilray’s presence in one of Europe’s most tightly regulated medical cannabis markets, it also advances its goal of building a unified global medical cannabis platform...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Is Travere Therapeutics (TVTX) Offering Value After Recent Share Price Swings?

If you are wondering whether Travere Therapeutics at around US$31.09 is offering fair value or an opportunity, you are not alone. This article is built to help you size that up clearly. The stock has had a mixed run, with a 5.6% gain over the last 7 days but an 18.6% decline over 30 days, while still sitting on a 52.0% return over 1 year and 43.1% over 3 years, compared with a 2.1% decline over 5 years. Recent coverage of Travere Therapeutics has focused on its position in the...
NYSE:MA
NYSE:MADiversified Financial

Mastercard (MA) Earnings Growth Of 16.3% Reinforces Premium Valuation Narrative

Latest FY 2025 earnings snapshot Mastercard (MA) has wrapped up FY 2025 with Q4 revenue of US$8.8b and basic EPS of US$4.53, setting the tone for a year where trailing 12 month revenue reached US$32.8b and EPS came in at US$16.54, alongside trailing earnings growth of 16.3% year over year. Over the last six reported quarters, the company has seen quarterly revenue move from US$7.5b in Q4 2024 to US$8.8b in Q4 2025. Basic EPS over that same span has ranged from US$3.54 in Q3 2024 to US$4.53 in...
NYSE:HTH
NYSE:HTHBanks

Hilltop Holdings Ups Dividend And Buybacks As Earnings Strengthen

Hilltop Holdings (NYSE:HTH) raised its quarterly dividend by 11% following its latest full year results. The company also authorized a new US$125 million share repurchase program. These capital return actions arrive after a year of improved profitability and strong financial performance. For you as an investor, this move puts fresh attention on Hilltop Holdings, a financial services company active in banking and other related lines of business. The higher dividend and new buyback plan come...
NYSE:CMC
NYSE:CMCMetals and Mining

Is It Too Late To Reassess Commercial Metals (CMC) After Its Recent 60% One Year Rally

If you are wondering whether Commercial Metals is still attractively priced after a strong run, this article walks through what the numbers currently say about its value. The stock recently closed at US$76.87, with returns of 11.1% over the last 30 days, 7.1% year to date, 60.6% over 1 year and 41.4% over 3 years. Over the last 7 days there has been a 0.8% decline that may have caught your eye. Recent news coverage has focused on Commercial Metals as an established name in steel and metal...
NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

Comcast (CMCSA) Margin Strength Reinforces Bullish Narratives Despite Flat Revenue Trend

Comcast (CMCSA) has wrapped up FY 2025 with fourth quarter revenue of US$32.3b and basic EPS of US$0.60, alongside trailing twelve month revenue of US$123.7b and EPS of US$5.39. Over the last six reported quarters, revenue has ranged from US$29.9b to US$32.3b, while quarterly EPS has moved between US$0.60 and US$2.99. This gives investors a clear view of how earnings per share translate off a large and relatively steady top line base. With a trailing net margin of 16.2% against 13.1% a year...
NYSE:MTX
NYSE:MTXChemicals

Minerals Technologies (MTX) Trailing Loss Challenges Bullish Narrative After Q4 Profit

Minerals Technologies (MTX) has wrapped up FY 2025 with fourth quarter revenue of US$519.5 million and EPS of US$1.19, set against a 12‑month backdrop where trailing revenue sat at about US$2.1 billion and EPS was slightly negative at US$0.59. Over recent quarters the company has seen quarterly revenue move from US$518.1 million in Q4 2024 to US$528.9 million in Q2 2025 and US$532.4 million in Q3 2025 before landing at US$519.5 million in Q4 2025. Over the same period, EPS shifted from...
NasdaqGS:BPOP
NasdaqGS:BPOPBanks

Is It Too Late To Consider Popular (BPOP) After Strong Multi Year Share Price Gains

If you are wondering whether Popular's share price still reflects good value or if most of the opportunity is already priced in, this article walks through the key signals you can use to form your own view. Popular's shares last closed at US$133.53, with returns of 9.5% over the past 7 days, 7.2% over 30 days, 6.0% year to date, 33.3% over 1 year, 106.6% over 3 years, and 149.1% over 5 years. These figures raise fair questions about what is now built into expectations and perceived...
NasdaqCM:GRRR
NasdaqCM:GRRRSoftware

A Look At Gorilla Technology Group (GRRR) Valuation As AI Trading Models Highlight Positive Near Term Outlook

AI-driven trading interest puts Gorilla Technology Group (GRRR) in focus Recent AI model outputs flagging positive near and mid-term sentiment for Gorilla Technology Group (GRRR) have pulled the stock into the spotlight, as institutional-style trading frameworks emphasize risk-reward trade setups instead of new fundamental catalysts. See our latest analysis for Gorilla Technology Group. Gorilla Technology Group’s share price has been volatile, with a 29.30% 1 month share price return and a...
NYSE:RMD
NYSE:RMDMedical Equipment

ResMed (RMD) Net Margin Strength In Q2 2026 Supports Bullish Earnings Narrative

ResMed Q2 2026 earnings in focus ResMed (RMD) has just posted its Q2 2026 earnings, with revenue of about US$1.4b and basic EPS of US$2.69 setting the tone for the latest quarter. The company reported revenue of US$1,282.1m in Q2 2025 and US$1,422.8m in Q2 2026, while basic EPS over the same quarters moved from US$2.35 to US$2.69. This gives investors a clearer view of both top line and per share performance. With trailing net profit margins at 27.5% and earnings growth already in focus, this...